Send me a link:

*Text messaging rates may apply.

 Dow Down0.72% Nasdaq Down0.50%

Sorrento Therapeutics, Inc. (SRNE)

-NasdaqCM
5.17 Down 0.10(1.90%) 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2014Dec 31, 2013Sep 30, 2013Jun 30, 2013
Total Revenue 976   101   84   142  
Cost of Revenue563  4   -   -  
Gross Profit 413   96   84   142  
Operating Expenses
Research Development6,107  3,395  2,082  2,142  
Selling General and Administrative3,385  2,565  995  1,507  
Non Recurring209  4,776   -  1,210  
Others586  491  313   -  
Total Operating Expenses10,287  11,226   -   -  
Operating Income or Loss (9,874) (11,130) (3,307) (4,717)
Income from Continuing Operations
Total Other Income/Expenses Net4  4  2  2  
Earnings Before Interest And Taxes(9,870)(11,126)(3,305)(4,715)
Interest Expense223  170  51  22  
Income Before Tax(10,093)(11,296)(3,356)(4,737)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(10,093)(11,296)(3,356)(4,737)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (10,093) (11,296) (3,356) (4,737)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (10,093) (11,296) (3,356) (4,737)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.